KPV 10 mg – Laboratory Research Material
KPV 10 mg – Laboratory Research Material
✓ In stock / Auf Lager · Swiss dispatch / Versand Schweiz · Tracked shipping / Tracking
AVELQOR10 · 10% off / Rabatt · Batch / COA documentation where available · Zahlungsarten im Checkout
Manual bank transfer can be selected during the normal Shopify checkout. Orders are processed after payment has been received and matched to the order.
Forschung, Spezifikationen & Dokumentation
Klar gegliederte Produktinformationen für Labor- und Analyseabläufe.
Draft Product Record
Internal catalogue draft. Not published or offered for sale until identity, batch linkage, analytical documentation and final labelling are confirmed.
KPV 10 mg – Laboratory Research Material
KPV 10 mg is listed as a lyophilized tripeptide research material for analytical, melanocortin-pathway and controlled non-clinical laboratory workflows.
Product Specifications
| Material | KPV (Lys-Pro-Val) |
| Form | Lyophilized laboratory research material |
| Declared content | 10 mg |
| Status | Draft — not published |
| Intended use | Laboratory and analytical research only |
Research Overview
The supplied HYBIO Peptide Product Reference Guide (2026) identifies KPV as the Lys-Pro-Val C-terminal tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH). It places KPV in anti-inflammatory and melanocortin-pathway research.
Mechanistic Research Context
The guide discusses melanocortin-pathway regulation and preclinical in-vitro or animal research involving intestinal and skin-related inflammatory models. These findings are experimental and do not establish a treatment or consumer-use claim for this material.
Laboratory Research Areas
- Melanocortin-pathway research
- Inflammatory-signalling models
- Intestinal and mucosal research models
- Skin-related cell and tissue research
- Comparative tripeptide characterization
Evidence & Limitations
The guide lists 5 mg as the most common lyophilized research format and also notes 10 mg formats. Human clinical evidence remains limited; research statements should therefore be interpreted as mechanistic or preclinical context rather than demonstrated clinical benefit.
Documentation & Traceability
Final identity, lot/batch linkage, analytical documentation and label details must be verified before publication. Documentation is linked to an Avelqor batch only where that relationship can be established.
COA & Batch Documentation · Quality & Testing
Laboratory Handling & Storage
Keep sealed and protected from light and moisture under the conditions stated on the final product label. Follow applicable laboratory SOPs and record batch identifiers and storage conditions. No reconstitution, dosing or administration instructions are provided.
Important Use Restriction
Research use only. Not for human or veterinary use, consumption or administration. No therapeutic, medical, cosmetic or household-use claim is made.
Reference basis: supplied HYBIO Peptide Product Reference Guide (2026); source statements have not been independently validated by Avelqor Labs.